Status:
COMPLETED
A Randomized Controlled Trial to Evaluate the Effectiveness of Electromyography (EMG)-Biofeedback in Patients With Fibromyalgia
Lead Sponsor:
Ludwig-Maximilians - University of Munich
Conditions:
Fibromyalgia
Eligibility:
FEMALE
18-65 years
Phase:
NA
Brief Summary
The purpose of this study is to determine whether EMG-Biofeedback is effective in the treatment of Fibromyalgia.
Detailed Description
The objective of this randomized controlled trial is to evaluate the effectiveness of EMG-biofeedback in patients with Fibromyalgia. The assessors are blinded to the group assignment. There are three ...
Eligibility Criteria
Inclusion
- fibromyalgia according to the American Congress of Rheumatology (ACR)-criteria and the criteria.
- female gender
- age between 18 and 65
- cognitive ability and sufficient German language skills to fill in health status questionnaires
- signed informed consent
Exclusion
- major medical disorders, i.e. cancer, chronic heart failure New York Heart Association (NYHA) IV or asthma requiring cortisone medication
- suffering from psychosis or major affective disorders
- substance abuse
- co-medication with opiates or benzodiazepine
- transmeridian flight in the last weeks
- shift-work
- gravity
Key Trial Info
Start Date :
April 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2006
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT02186756
Start Date
April 1 2005
End Date
July 1 2006
Last Update
July 10 2014
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.